Vanguard Group Inc Roivant Sciences Ltd. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Vanguard Group Inc holds 44,087,287 shares of ROIV stock, worth $467 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
44,087,287
Previous 41,683,055
5.77%
Holding current value
$467 Million
Previous $481 Million
8.43%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$697 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$658 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$507 Million1.91% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$375 Million0.01% of portfolio
-
Morgan Stanley New York, NY34.6MShares$367 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.47B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...